To List Or Not To List; That Is The Question – The FTC Signals The Potential For Greater Scrutiny Of Patent Information Submissions To FDA - Food and Drugs Law
Listing patent information in the Orange Book is a matter of judgment, but that judgment call is about to get a bit more scrutiny.